Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue
PhytoHealth Corporation
PhytoHealth Corporation
Sanko University
Medical College of Wisconsin
Wake Forest University Health Sciences
University of Rochester
The Hospital for Sick Children
Massachusetts General Hospital
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
Johns Hopkins University
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
University of Michigan
University Hospital of North Norway
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
University of Southern California
Teva Branded Pharmaceutical Products R&D, Inc.
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
South Sound Care Foundation
St. Jude Children's Research Hospital
Meriyana Bio Inc.
Ann & Robert H Lurie Children's Hospital of Chicago
Centre Jean Perrin
M.D. Anderson Cancer Center
University of Aarhus
University Health Network, Toronto
University of South Florida
H. Lee Moffitt Cancer Center and Research Institute
Massachusetts General Hospital
Rutgers, The State University of New Jersey